Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

Ítems similars

• A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
  per: Cheadle, E J, et al.
  Publicat: (2017)
• Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector CDS(+) T cells
  per: Dovedi, Simon J., et al.
  Publicat: (2016)
• Novel TLR7 agonist stimulates activity of CIK/NK immunological effector cells to enhance antitumor cytotoxicity
  per: Gao, Dong, et al.
  Publicat: (2018)
• Pathogen-like Nanoassemblies of Covalently Linked TLR Agonists Enhance CD8 and NK Cell-Mediated Antitumor Immunity
  per: Manna, Saikat, et al.
  Publicat: (2020)
• The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade
  per: Dovedi, S J, et al.
  Publicat: (2015)